v3.26.1
SHARE-BASED PAYMENT (Tables)
 12 Months Ended
Dec. 31, 2025
Disclosure of terms and conditions of share-based payment arrangement [abstract]  
Schedule of Cash-Settled Share-Based Payment Transactions
Below, the position of outstanding shares granted:
12.31.2023Movements in 202412.31.2024Movements in 202512.31.2025
Grant MonthVesting MonthFair value of the share at the grant date R$ (i)Number of shares grantedNumber grantedQuantity cancelled or adjustedNumber settledNumber of shares granted (ii)Fair value of the liability US$ (iii)Number grantedQuantity cancelled or adjustedNumber settledNumber of shares granted (ii)Fair value of the liability US$ (iii)
Recurring plans
03.201903.202419.30 164,969 — — (164,969)— — — — — — — 
03.202003.202516.95 341,214 — (1,404)(168,061)171,749 1.5 — (2,405)(169,344)— — 
03.202103.202411.29 1,960,022 — — (1,960,022)— — — — — — — 
03.202203.202517.61 2,039,084 — — — 2,039,084 17.3 — (33,166)(2,005,918)— — 
03.202303.202616.35 3,359,022 — — — 3,359,022 18.6 — 165,703 — 3,524,725 52.2 
03.202403.202722.95 — 2,537,146 — — 2,537,146 6.4 — (42,200)— 2,494,946 23.9 
03.202503.202862.98 — — — — — — 1,042,952 — — 1,042,952 4.5 
Non-recurring plans (iv)
09.202209.202713.69 13,611,375 — — — 13,611,375 45.6 — — — 13,611,375 121.9 
11.202211.202612.58 4,530,448 — — — 4,530,448 18.6 — — — 4,530,448 50.0 
09.202309.202718.55 1,771,760 — (9,935)— 1,761,825 4.3 — — — 1,761,825 13.7 
02.202402.202822.43 — 4,088,971 (99,386)— 3,989,585 8.3 — (16,179)— 3,973,406 26.6 
32,000,234 120.6 30,939,677292.8 
(i)The fair value of the share at the grant date is determined based on the volume‑weighted average price (VWAP) of EMBJ3 shares traded on B3 over the 30 trading sessions immediately prior to the 10th day preceding the date on which the Board of Directors sets the respective values.
(ii)The number of shares presented in this column will be recognized over the vesting period. Accordingly, it differs from the number of shares measured at fair value at the reporting date.
(iii)The fair value of the share used in measuring the fair value of the liability, amounting to US$15.67 (2024: US$9.07), was determined based on the volume‑weighted average price (VWAP) of EMBJ3 shares traded on B3 over the 10 trading sessions beginning on the 15th day of the relevant reference month. When applicable, dividends effectively distributed, including interest on equity, are added to the share’s fair value. This amount, together with the applicable payroll charges, is presented as other payables (Note 20).
(iv)For participants in these plans, advances are made on each anniversary of the grant date. As of December 31, 2025, advances made since the grant date total US$32.2 (2024: US$16.8), and the fair value of the liability is presented net of this amount.